- Home
- KYMR vs AGNC Comparison
KYMR vs AGNC Comparison
Compare KYMR & AGNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | AGNC |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6B | 12.6B |
| IPO Year | 2020 | 2008 |
Fundamental Metrics
Financial Performance| Metric | KYMR | AGNC |
|---|---|---|
| Price | $109.69 | $9.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 26 | 13 |
| Target Price | ★ $107.72 | $11.03 |
| AVG Volume (30 Days) | 597.5K | ★ 26.8M |
| Earning Date | 04-30-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 13.13% |
| EPS Growth | N/A | ★ 58.06 |
| EPS | N/A | ★ 0.37 |
| Revenue | ★ $39,211,000.00 | N/A |
| Revenue This Year | $10.61 | $0.33 |
| Revenue Next Year | $8.17 | $1.16 |
| P/E Ratio | ★ N/A | $25.43 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $54.38 | $9.39 |
| 52 Week High | $130.05 | $12.19 |
Technical Indicators
Market Signals| Indicator | KYMR | AGNC |
|---|---|---|
| Relative Strength Index (RSI) | 38.87 | 22.78 |
| Support Level | $76.40 | N/A |
| Resistance Level | $120.37 | $10.62 |
| Average True Range (ATR) | 4.55 | 0.20 |
| MACD | -0.98 | -0.06 |
| Stochastic Oscillator | 3.03 | 1.74 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.
About AGNC AGNC Investment Corp.
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.